Connect with us


SARS-CoV-2 anti-nucleocapsid antibodies reduce risk of reinfection for at least eight months – News-Medical.Net

A new study concludes that at least with predominantly wild-type variants, the risk of reinfection with the virus among unvaccinated…

Article feature image

As the coronavirus disease 2019 (COVID-19) pandemic continues to take a heavy toll on the world population, scientists are seeking to identify the protective impact of prior infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Click here to view the original article.

You might also like ...

Article feature image
‘You’re so mature for your age’ isn’t always a compliment. Sometimes it’s from trauma. – USA TODAY
Article feature image
Clinical study shows therapeutic sleep training for older adults can prevent depression – USA TODAY